| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Sullivan Timothy Eugene is a Chief Financial Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,856 | $22.19 | $85,553.84 | -3.5% | +91.2% | - | |
| Oct 21, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $28.03 | $280,300.00 | -8.3% | -27.7% | - | |
| Sep 8, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 42,729 | $27.85 | $1,190,129.94 | -20.0% | -11.6% | - | |
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 546 | $29.52 | $16,119.89 | -0.4% | -38.2% | -21.8% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,088 | $30.43 | $93,953.94 | -2.3% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,730 | $29.96 | $51,827.69 | -2.0% | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 2,170 | $28.70 | $62,283.56 | -2.4% | -32.4% | -25.4% | |
| Apr 1, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 4,000 | $58.66 | $234,640.00 | -4.1% | -39.2% | -62.0% | |
| Mar 1, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 6,000 | $63.22 | $379,340.00 | -3.1% | -36.2% | -60.6% | |
| Feb 12, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,431 | $67.77 | $96,974.43 | -1.5% | -36.5% | -57.9% |